本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Acumen Pharmaceuticals, Inc.

1.42
-0.0600-4.05%
盤後1.540.1201+8.46%19:17 EDT
成交量:174.36萬
成交額:278.14萬
市值:8,601.43萬
市盈率:-0.63
高:1.75
開:1.50
低:1.42
收:1.48
52周最高:3.36
52周最低:0.8551
股本:6,057.34萬
流通股本:3,292.95萬
量比:4.09
換手率:5.29%
股息:- -
股息率:- -
每股收益(TTM):-2.2658
每股收益(LYR):-1.7051
淨資產收益率:-75.71%
總資產收益率:-39.06%
市淨率:0.73
市盈率(LYR):-0.83

資料載入中...

2025/08/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/12

重要事件披露

Form 8-K - Current report
2025/07/15

重要事件披露

Form 8-K - Current report
2025/06/05

重要事件披露

Form 8-K - Current report
2025/05/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/05/13

重要事件披露

Form 8-K - Current report
2025/03/27

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/27

重要事件披露

Form 8-K - Current report
2025/01/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities